Solventum Corp reported $927M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.6B 330M Jun/2026
Align Technology USD 462.67M 2.67M Jun/2026
Baxter International USD 735M 7M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Cencora USD 1.98B 182.27M Mar/2026
Dexcom USD 358.7M 9M Jun/2026
Insulet USD 344.8M 27.6M Jun/2026
Solventum Corp USD 927M 144M Jun/2026
West Pharmaceutical Services USD 117.6M 18.1M Jun/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026